Vancomycin-resistant enterococci (VRE) as normal flora of the intestine in patients at a tertiary care hospital

Annals of Saudi Medicine

Volumn 16, Issue 6, 1996, Pages 625-628

  Qadri, S M Hussain ^a   Postle, A Gerald ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CIPROFLOXACIN; GENTAMICIN; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; CHILD; CLINICAL ARTICLE; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; FECES CULTURE; FEMALE; HOSPITAL PATIENT; HUMAN; INFANT; MALE; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 0030511904     PISSN: 02564947     EISSN: None     Source Type: Journal    
DOI: 10.5144/0256-4947.1996.625     Document Type: Article

References (34)

1. Emori TG, Gaynes RP. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev 1993;6:428-42.
2. Schalbern DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am J Med 1991;I Suppl 3B:72S-5S.
3. Grayson L, Eliopoulos GM, Wennerstern C, Rouff K, De Girolami P, Fenaro MJ, Moellering R. Increasing resistance to β-lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year review at one institution. Antimicrob Agents Chemother 1991;35:2180-4.
4. Watanakunakorn W. Enterococci from blood cultures during 1980-1989. Susceptibilities to ampicillin, penicillin and vancomycin. J Antimicrob Chemother 1990;26:602-4.
5. Murray BE. The life and times of the Enterococcus. Clin Microbiol Rev 1990;3:46-65.
6. Leclercq R, Derlot E, Duval J, Courvalin P. Plasmid mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988;319:157-61.
7. Montecalvo MA, Horowitz H, Gedris C, et al. Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother 1994;38:1363-7.
8. Handwerger S, Perlman DC, Altarac D, McAuliffe V. Concommitant high-level vancomycin and penicillin resistance in clinical isolates of enterococci. Clin Infect Dis 1992;14:655-61.
9. Uttley AHC, George RC, Naidoo J, et al. High-level vancomycin-resistant enterococci causing hospital infections. Epidemiol Infec 1989;103:173-81.
10. Qadri SMH, Quinibi WY, Al-Ballaa SR, Kadhi Y, Burdette JM. Vancomycin-resistant Enterococcus: a case report and review of literature. Ann Saudi Med 1993;13:289-93.
11. Leclercq R, Derlot E, Weber M, et al. Transferable vancomycin and teicoplanin resistance in Enterococcus faecium. Antimicrob Agents Chemother 1989;33-10-5.
12. Shlaes DM, Al-Obeid S, Shlaes JH, Williamson R. Activity of various glycopeptides against an inducibly vancomycin-resistant strain of Enterococcus faecium (D366). J Infect Dis 1989;159:1132-5.
13. Shay DK, Goldman DA, Jarvis WR. Reducing the spread of antimicrobial-resistant microorganisms. Control of vancomycin-resistant enterococci. Pediatr Clin North America 1995;42:703-16.
14. Spera RV Jr, Farber BF. Multidrug-resistant Enterococcus faecium. An untreatable nosocomial pathogen. Drugs 1994;48:678-88.
15. Linden P, Pasculle AW, Kramer DJ, Jusne S, Manez R. The duration of fecal carriage of vancomycin-resistant Enterococcus faecium (VREF). University of Pittsburgh Medical Center, Pittsburgh, PA. Abstract 34th Interscience Conference on Antimicrob Agents Chemother, Orlando, Fla. 1994;J-150.
16. Murray PR, Baron MJ, Pfaller MA, Tenover FC, Yolken RH. Manual of Clinical Laboratory. 6th ed. Washington, DC: American Society for Microbiology, 1995.
17. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests. Approved Standard M2-A5. National Committee for Clinical Laboratory Standards, Villanova, PA 1993.
18. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Approved standard M7-A3. National Committee for Clinical Laboratory Standards, Villanova, PA 1993.
19. Rubin LG, Tucci V, Cercenado E, Eliopoulos G, Isenberg HD. Vancomycin-resistant Enterococcus faecium in hospitalized children. Infect Control Hosp Epidemiol 1992;13:700-5.
20. Karanfil LV, Murphy M, Josephson A, et al. A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit. Infect Control Hosp Epidemiol 1992;13:195-200.
21. Handwerger S, Raucher B, Altarac D, et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis 1993;16:750-5.
22. Hospital Infection Control Advisory Committee (HICPAC). Recommendations for preventing the spread of vancomycin resistance. Infec Control Hosp Epidemiol 1995;16:105-13.
23. Centers for Disease Control and Prevention. Nosocomial Enterococci resistant to vancomycin - United States, 1989-1993. MMWR 1993;42:597-9.
24. Jorden JZ, Bates J, Griffiths DT. Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium. J Antimicrob Chemother 1994;34:515-28.
25. Montecalvo M, Carraher P, Gedris C, Van Horn K, Wormser GP. Persistence of perianal colonization with vancomycin-resistant enterococci (VRE) in adult oncology patients. Abstracts 34th Interscience Conference on Antimicrob Agents Chemother, Orlando, Fla., 1994; J152.
26. Gordts B, Clabys K, Jannes H, Van Landuyt HW. Are vancomycin-resistant enterococci (VRE) normal inhabitants of the G.I. tract of hospitalized patients? Abstracts 34th Interscience Conference on Antimicrob Agents Chemother, Orlando, Fla., 1994;J151.
27. Osoba AO, Jeha MT, Bakheshwain S, Al-Anazi K, Bertlett F. Septicemia due to vancomycin-resistant Enterococcus: a case report. Saudi Med J 1995;16:67-9.
28. Klare I, Heier H, Claus H, Witte W. Environmental strains of Enterococcus faecium with inducible high-level resistance to glycopeptides. FEMS Microbiol Lett 1993;106:23-90.
29. Klare I, Heier H, Claus H, Reissbrodt R, Witte W. van A-mediated high-level glycopeptide resistance in Enterococcus faecium from animal husbandry. FEMS Microbiol Lett 125:165-72.
30. Torres C, Reguera JA, Sanmartin MJ, Perez-Diaz JC, Baquero F. van A-mediated vancomycin-resistant Enterococcus spp in sewage. J Antimicrob Chemother 1994;33:553-61.
31. Klare I, Heier H, Claus H, Bohme G, Marin S, Seitmann G, Hakenbeck R, Antanassova V, Witte W. Enterococcus faecium strains with van A-mediated high-level glycopeptide resistance isolated from animal foodstuffs and fecal samples of humans in the community. Microbial Drug Res 1995;1:265-72.
32. Aarestrup FM. Occurrence Of glycopeptide resistance among Enterococcus faecium isolates from conventional and ecological poultry farms. Microbial Drug Res 1995;1:255-7.
33. Frieden TR, Munsiff SS, Lowe DE, et al. Emergence of vancomycin-resistant enterococci in New York City. Lancet 1993;342:76-9.
34. Willey BM, Kreiswirth BN, Simor AE, et al. Detection of vancomycin resistance in Enterococcus species. J Clin Microbiol 1992;30:1621-4.